- Previous Close
171.65 - Open
172.50 - Bid 150.65 x --
- Ask 149.85 x --
- Day's Range
146.70 - 173.95 - 52 Week Range
80.00 - 180.95 - Volume
86,804 - Avg. Volume
89,082 - Market Cap (intraday)
28.282B - Beta (5Y Monthly) 0.46
- PE Ratio (TTM)
-- - EPS (TTM)
-12.48 - Earnings Date May 19, 2025 - May 23, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Jul 28, 2016
- 1y Target Est
190.00
Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include antioxidants comprises Butylated Hydroxy Toluene and Ascorbyl palmitate; and emulsifiers, mold inhibitors, antibacterial agents, toxin binders, pellet binders, disinfectants, energizers, preservatives, thickening agents, and growth promoters, as well as plant-based antioxidants, such as mixed tocopherols, green tea extract, and rosemary extract that are used to enhance the shelf life under the Xtendra and NaSure brands. It also provides aroma ingredients, including vanillin and ethyl vanillin; health and wellness products; and performance chemicals, such as hydroquinone and catechol. Its products are used in food and beverage, pet food, animal nutrition, rendering, health and wellbeing, chemicals, biofuel, aroma technical, fragrance, and flavor industries. The company was formerly known as Camlin Fine Chemicals Limited and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India.
www.camlinfs.com624
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: CAMLINFINE.BO
View MorePerformance Overview: CAMLINFINE.BO
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CAMLINFINE.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CAMLINFINE.BO
View MoreValuation Measures
Market Cap
28.35B
Enterprise Value
34.99B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.61
Price/Book (mrq)
4.11
Enterprise Value/Revenue
2.14
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-13.03%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
16.54B
Net Income Avi to Common (ttm)
-2.15B
Diluted EPS (ttm)
-12.48
Balance Sheet and Cash Flow
Total Cash (mrq)
905.9M
Total Debt/Equity (mrq)
115.27%
Levered Free Cash Flow (ttm)
--